Dr. Son is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
117 VIP Dr
Suite 120
Wexford, PA 15090Phone+1 724-935-1130
Summary
- I obtained my Medical Degree at The Medical College of Georgia, completed my residency in Internal Medicine at Cedars-Sinai Medical Center, and am board certified in Internal Medicine. I completed my clinical Rheumatology fellowship at The Johns Hopkins University with a focus in Musculoskeletal Ultrasound with RhMSUS certification. I am a board-certified rheumatologist in practice at UPMC.
Education & Training
Johns Hopkins UniversityFellowship, Rheumatology, 2021- Johns Hopkins University School of MedicineRheumatology, 2021
Cedars-Sinai Medical CenterResidency, Internal Medicine, 2016 - 2019
Medical College of Georgia at Augusta UniversityClass of 2016
Certifications & Licensure
MD State Medical License 2021 - 2025
PA State Medical License 2024 - 2024
CA State Medical License 2018 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- 3 citationsLow levels of anti-cyclic citrullinated peptide (CCP) 3.1 associated with diseases other than rheumatoid arthritis.James J Son, Mariko L. Ishimori, James Mirocha, Michael H. Weisman, Lindsy J. Forbess
Medicine. 2021-04-23 - 2 citationsSystemic Lupus Erythematosus and Common Variable Immunodeficiency.Antoine Azar, Nawras Aldaoud, Dylan Hardenbergh, Rebecca Krimins, James Son
Journal of Clinical Rheumatology. 2021-03-23 - 15 citationsRegulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell diseaseAbhishek A. Mangaonkar, Fahim Thawer, James Son, Germame Ajebo, Hongyan Xu
British Journal of Haematology. 2020-02-06
Journal Articles
- Low levels of anti-cyclic citrullinated peptide (CCP) 3.1 associated with diseases other than rheumatoid arthritisJames J Son, Mariko Ishimori, James Mirocha, Michael H Weisman, Lindsy J Forbess, Medicine, 4/23/2021
- Systemic Lupus Erythematosus and Common Variable ImmunodeficiencyAntoine Azar, Nawras Aldaoud, Dylan Hardenbergh, Rebecca Krimins, James Son, Jennifer Shiroky, Homa Timlin, Journal of Clinical Rheumatology, 3/23/2021
Abstracts/Posters
- The Newest Generation Cyclic Citrullinated Peptide (CCP) 3.1 Assay in the Diagnosis of Rheumatoid ArthritisSon J, Ishimori M, Forbess LJ, American College of Rheumatology, Chicago, IL, 10/2018
- Spondyloarthritis Following Treatment with Vedolizumab in a Patient with Inflammatory Bowel DiseaseSon J, Scaramangas-Plumley D, Melmed G, Weisman, MH, American College of Physicians, San Diego, CA, 10/2016
- Transfusional Iron Overload In An Adult Sickle Cell Disease Population: Epidemiology, Prevalence, and ManagementSon J, Xu H, Barrett N, Bowman L, Wells L, Clair B, Kutlar, A, American Society of Hematology, New Orleans, LA, 12/2013
Research History
- ORISE Research FellowResearch Fellow at The Centers for Disease Control and Prevention (Atlanta, GA) in the National Center for Emerging and Zoonotic Infectious Diseases, Rickettsial Zoonoses Branch.2010 - 2012
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
